The Control Study on Yinxingdamo Injection in the Treatment of Acute Facial Palsy

ZHANG Chun-Yuan,BAO Shi-Yao,WEN Zhong-Min
DOI: https://doi.org/10.3969/j.issn.1008-0678.2008.02.013
2008-01-01
Abstract:Aim:To evaluate the effect of Yinxingdamo injection on the acute idiopathic facial palsy. Methods:62 patients diagnosed as acute idiopathic facial palsy were randomly assigned to Yinxingdamo injection group (n=31) used Yinxingdamo 25 mL per day , and comparison group (n=31) used Danshen 20 mL per day separately for fourteen days. The same dose of prednisone, antivirus drug and vitamin B were used in each group. House-Brackmann facial nerve grading system was used to evaluate the outcome of treatments at the time of 1 week, 3 weeks and 4 weeks. Results:Fifteen patients(48.38 %) recovered completely in Yinxingdamo group comparing with 8 patients (25.80 %) in Danshen group (P <0.05) after 3 weeks treatment, and 23 patients (74.19 %) recovered completely in Yinxingdamo group comparing with 14 patients (45.16 %) in Danshen group ( P<0.05) at the end of 4 weeks. Conclusion :Yinxingdamo injection is superior to Danshen injection in treating acute idiopathic facial palsy.
What problem does this paper attempt to address?